Provident Financial PLC Share Price Cinnober Boat
Stocks
PFG
GB00B1Z4ST84
Consumer Lending
OTC Markets Traded| Market Cap | 18Cr 24Cr 21Cr 20Cr 34Cr 2.32TCr 34Cr 239.96Cr 93Cr 1.18TCr 91Cr 89Cr 3.81TCr | P/E 2026 * |
15.4x | P/E 2027 * | 4.9x |
|---|---|---|---|---|---|
| Enterprise Value | 18Cr 24Cr 21Cr 20Cr 34Cr 2.32TCr 34Cr 239.96Cr 93Cr 1.18TCr 91Cr 89Cr 3.81TCr | EV / Sales 2026 * |
0.38x | EV / Sales 2027 * | 0.35x |
| Free-Float |
88.53% | Yield 2026 * |
1.37% | Yield 2027 * | 5.17% |
Last Transcript: Provident Financial PLC
| 30/07 | Berenberg raises Rio Tinto; HSBC ups Centrica | AN |
| 09/03 | JPMorgan cuts Antofagasta and Rio Tinto | AN |
| 16/24/16 | Barclays raises Travis Perkins to 'overweight' | AN |
| 13/24/13 | Vanquis shares up ahead of trading update | AN |
| 09/24/09 | NatWest target raised, other lenders backed | AN |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 60 | 01/08/2023 | |
David Watts
DFI | Director of Finance/CFO | 60 | 01/11/2023 |
Ian Fielder
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Graham Lindsay
BRD | Director/Board Member | 68 | 01/04/2019 |
Michele Greene
BRD | Director/Board Member | 60 | 09/03/2023 |
Peter Estlin
CHM | Chairman | 65 | 15/09/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 24Cr | |
| +1.52% | -4.17% | -1.57% | +27.48% | 6.47TCr | |
| +2.01% | -0.98% | -36.12% | +47.52% | 3.45TCr | |
| +0.49% | -4.40% | -13.00% | +12.27% | 2.95TCr | |
| +0.76% | -0.60% | +63.06% | +156.66% | 2.45TCr | |
| +1.94% | -2.80% | -1.80% | +132.07% | 2.37TCr | |
| -1.31% | -2.24% | -41.04% | +120.77% | 2.14TCr | |
| -0.09% | -1.26% | -24.73% | -1.20% | 1.56TCr | |
| -1.30% | -6.66% | +4.31% | +40.37% | 1.48TCr | |
| +0.86% | -3.47% | - | - | 1.49TCr | |
| Average | +0.42% | -2.52% | -6.36% | +66.99% | 2.71TCr | |
| Weighted average by Cap. | +0.69% | -2.40% | -6.24% | +60.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 48Cr 64Cr 56Cr 53Cr 90Cr 6.12TCr 91Cr 633.49Cr 245.36Cr 3.13TCr 239.83Cr 234.64Cr 10TCr | 52Cr 68Cr 60Cr 57Cr 97Cr 6.55TCr 97Cr 677.39Cr 262.37Cr 3.34TCr 256.45Cr 250.9Cr 11TCr |
| Net income | 1.5Cr 1.99Cr 1.74Cr 1.65Cr 2.81Cr 190.35Cr 2.83Cr 20Cr 7.63Cr 97Cr 7.46Cr 7.3Cr 312.54Cr | 4.02Cr 5.33Cr 4.67Cr 4.41Cr 7.53Cr 510.57Cr 7.59Cr 53Cr 20Cr 260.84Cr 20Cr 20Cr 838.31Cr |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
